<DOC>
	<DOC>NCT00805155</DOC>
	<brief_summary>The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Mometasone Furoate 0.1% Topical Lotions in healthy, female subjects.</brief_summary>
	<brief_title>Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions</brief_title>
	<detailed_description />
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Nontobacco using female subjects, 18 to 50 years of age Demonstrated blanching response to Reference Drug Body Mass Index (BMI) of 30 or less Good health as determined by lack of clinically significant abnormalities in medical history and clinical assessment, as judged by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing Use of any tobacco products in the 30 days prior to study dosing Use of any dermatological drug therapy on the flexor surface of the forearms within 30 days of dosing Receipt of any drugs as part of a research study within 30 days prior to study dosing Pregnant or lactating</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Mometasone Furoate</keyword>
</DOC>